Equibles does not estimate personal net worth.
Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CMPX alertsThomas Schuetz, MD, PhD is recorded as CEO at Compass Therapeutics, Inc. (CMPX) since May 28, 2024 and Chairman at Compass Therapeutics, Inc. (CMPX) since January 9, 2024. Thomas Schuetz, MD, PhD has spoken on 1 investor event across 1 company, most recently for Compass Therapeutics, Inc. on June 4, 2026. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Vered Bisker-Leib, PhD (CEO and Board Member) and 7 others.
“I'll go through a few slides, and then, as Maury mentioned, we'll have some Q&A following a brief presentation. Just one quick reminder, I will be making forward-looking statements today, and I will refer you to our regulatory filings for descriptions of those.”
2024-05-28–present
2024-01-09–present
Biotechnology · Healthcare
CEO, Chairman
2024-01-09–present
